Status:
UNKNOWN
Azelaic Acid Iontophoresis Versus Topical Azelaic Acid Cream in the Treatment of Melasma
Lead Sponsor:
Medical University of Vienna
Conditions:
Melasma
Eligibility:
FEMALE
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this prospective, randomized, controlled, single-blinded investigation is to study the efficacy, tolerability and safety of azelaic acid iontophoresis (AAI) versus topical treatment wit...
Detailed Description
Patients will be randomized and allocated in concealed manner to one of the two treatment arms: AAI or topical azelaic acid cream. Azelaic acid iontophoresis treatment schedule: Patients randomized ...
Eligibility Criteria
Inclusion
- Woman
- MASI - Score over 6
- Age: over 18 years
- Skin Type: III, IV, V
Exclusion
- Skin Type: I, II, VI
- Pregnant or lactating women
- Local therapy of intent-to-treat area within the last 6 month
- Patient with a pacemaker or metal implant
- Epileptic
- Mental incompetence to understand the protocol
- Known allergic reactions to one of used substances
- Serious encroachment on physical condition
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT00848458
Start Date
January 1 2009
Last Update
July 15 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University Vienna / Depatment of Dermatology
Vienna, Austria, 1180